CenturyLink Inc. Sank to a New Low; Loser to Watch (CTL, PLUG, AFFY)

Los Angelas, CA -- (SBWIRE) -- 02/15/2013 -- CenturyLink, Inc. (NYSE:CTL) reported fourth quarter adjusted net income of $0.67 per share after the bell Wednesday, compared to $0.55 a year ago. The consensus estimate was for EPS of $0.68. The Company expects to report first quarter adjusted EPS of $0.67 to $0.72 and between $2.50 and $2.70 for the full year 2013. The consensus estimates are for EPS of $0.66 and $2.84.

CenturyLink gapped open sharply lower Thursday and slipped further around midday. The stock finished down by 9.42 at $32.27 on the highest volume of the year. CenturyLink dropped below both its 50 and 200-day moving averages and plunged to a new low for the year.

CenturyLink, Inc. provides a range of communications services. Its communications services include local and long-distance, network access, private line (including special access), public access, broadband, data, managed hosting (including cloud hosting), colocation, wireless and video services. In certain local and regional markets, CenturyLink also provides local access and fiber transport services to local exchange carriers and security monitoring. Its segments include Regional markets, Business markets, Wholesale markets and Savvis operations.

Is CTL a Buying Opportunity After Yesterday’s Slump? Find Out Here

Plug Power Inc (NASDAQ:PLUG) declared that it has priced an underwritten public offering of 18,910,000 shares of its common stock and accompanying warrants to buy 18,910,000 shares of common stock. The shares and the warrants will be sold together, with each grouping entailing one share of common stock and one warrant to purchase one share of common stock, at a price to the public of $0.15 per fixed combination for gross proceeds of about $2.8 million.

In the last trading session, Plug Power Inc plunged -52.02% to close at $0.120 and its total traded volume was 27.72 million shares.

Plug Power Inc. is a provider of alternative energy technology focused on the design, development, commercialization and manufacture of fuel cell systems for the industrial off-road (forklift or material handling) market. The Company is focused on proton exchange membrane (PEM), fuels cell and fuel processing technologies and fuel cell/battery hybrid technologies, from which multiple products are available.

Is PLUG A Buy Or Sell At These Levels? Find Out Here

Affymax, Inc. (NASDAQ:AFFY) tumbled 6.92%, extending three-day losing streak after the drug maker said a key customer, Fresenius Medical Care North America, will pause expansion of the pilot program using the company’s anemia drug Omontys in dialysis centers.

Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. Peginesatide is a synthetic peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells

How Should Investors React To GMCR Now? Find Out Here

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com